176 related articles for article (PubMed ID: 25551808)
21. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window.
Rosenberg GA; Estrada EY; Dencoff JE; Stetler-Stevenson WG
Brain Res; 1995 Dec; 703(1-2):151-5. PubMed ID: 8719627
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Zervos EE; Shafii AE; Rosemurgy AS
J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
[TBL] [Abstract][Full Text] [Related]
23. Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal function.
Ziswiler R; Daniel C; Franz E; Marti HP
Exp Nephrol; 2001; 9(2):118-24. PubMed ID: 11150860
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.
Wang J; Tsirka SE
Brain; 2005 Jul; 128(Pt 7):1622-33. PubMed ID: 15800021
[TBL] [Abstract][Full Text] [Related]
25. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain.
Chen W; Hartman R; Ayer R; Marcantonio S; Kamper J; Tang J; Zhang JH
J Neurochem; 2009 Nov; 111(3):726-36. PubMed ID: 19712057
[TBL] [Abstract][Full Text] [Related]
27. Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery.
Pagliuca C; Scaglione E; Carraturo F; Mantova G; Marino MM; Pishbin MV; Pagliarulo C; Colicchio R; Salvatore P
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762464
[TBL] [Abstract][Full Text] [Related]
28. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.
Sellner J; Leib SL
Neurobiol Dis; 2006 Mar; 21(3):647-56. PubMed ID: 16257222
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-9: dual role and temporal profile in intracerebral hemorrhage.
Chang JJ; Emanuel BA; Mack WJ; Tsivgoulis G; Alexandrov AV
J Stroke Cerebrovasc Dis; 2014; 23(10):2498-2505. PubMed ID: 25306400
[TBL] [Abstract][Full Text] [Related]
30. Scutellaria baicalensis attenuates blood-brain barrier disruption after intracerebral hemorrhage in rats.
Shin JW; Kang HC; Shim J; Sohn NW
Am J Chin Med; 2012; 40(1):85-96. PubMed ID: 22298450
[TBL] [Abstract][Full Text] [Related]
31. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8.
Schubert-Unkmeir A; Konrad C; Slanina H; Czapek F; Hebling S; Frosch M
PLoS Pathog; 2010 Apr; 6(4):e1000874. PubMed ID: 20442866
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis.
Mazumder MK; Bhattacharya P; Borah A
Med Hypotheses; 2014 Dec; 83(6):697-701. PubMed ID: 25459137
[TBL] [Abstract][Full Text] [Related]
33. Influence of the matrix metalloproteinase inhibitor batimastat (BB-94) on periodontal bone destruction in Sprague-Dawley rats.
Björnsson MJ; Havemose-Poulsen A; Stoltze K; Holmstrup P
J Periodontal Res; 2004 Aug; 39(4):269-74. PubMed ID: 15206921
[TBL] [Abstract][Full Text] [Related]
34. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper.
Rucavado A; Escalante T; Teixeira CF; Fernándes CM; Diaz C; Gutiérrez JM
Mediators Inflamm; 2002 Apr; 11(2):121-8. PubMed ID: 12061424
[TBL] [Abstract][Full Text] [Related]
35. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Muhammad S; Planz O; Schwaninger M
Cerebrovasc Dis Extra; 2016; 6(2):50-9. PubMed ID: 27560521
[TBL] [Abstract][Full Text] [Related]
36. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
Neuroscience; 2012 Mar; 205():39-48. PubMed ID: 22244977
[TBL] [Abstract][Full Text] [Related]
37. Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1/MMP-9.
Wu J; Zhao D; Wu S; Wang D
Eur J Pharmacol; 2015 Feb; 748():30-6. PubMed ID: 25523481
[TBL] [Abstract][Full Text] [Related]
38. Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Jang JW; Lee JK; Hur H; Kim TW; Joo SP; Piao MS
J Neurol Sci; 2014 Apr; 339(1-2):75-80. PubMed ID: 24507948
[TBL] [Abstract][Full Text] [Related]
39. Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1.
Ashley SL; Pretto CD; Stier MT; Kadiyala P; Castro-Jorge L; Hsu TH; Doherty R; Carnahan KE; Castro MG; Lowenstein PR; Spindler KR
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053109
[TBL] [Abstract][Full Text] [Related]
40. Increased activity of Rho kinase contributes to hemoglobin-induced early disruption of the blood-brain barrier in vivo after the occurrence of intracerebral hemorrhage.
Fu Z; Chen Y; Qin F; Yang S; Deng X; Ding R; Feng L; Li W; Zhu J
Int J Clin Exp Pathol; 2014; 7(11):7844-53. PubMed ID: 25550824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
